Published on 19 Mar 2023 on Simply Wall St. via Yahoo Finance
Shareholders may not want to ignore the US$4.3m worth sales made by Moderna, Inc. (NASDAQ:MRNA)...
While Moderna, Inc. (NASDAQ:MRNA) shareholders have had a good week with the stock up 8.5%, they shouldn't let their guards down. In spite of the relatively cheap prices, insiders made the decision to sell US$4.3m worth of stock in the last 12 months. This could be a warning indicator of vulnerabilities in the future.
Although we don't think shareholders should simply follow insider transactions, we would consider it foolish to ignore insider transactions altogether.
See our latest analysis for Moderna